Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease

Amanda J. Page, L. Ashley Blackshaw

Research output: Chapter in Book/Report/Conference proceedingChapter

29 Citations (Scopus)

Abstract

Oesophageal pain is one of the most common reasons for physician consultation and/or seeking medication. It is most often caused by acid reflux from the stomach, but can also result from contractions of the oesophageal muscle. Different forms of pain are evoked by oesophageal acid, including heartburn and non-cardiac chest pain, but the basic mechanisms and pathways by which these are generated remain to be elucidated. Both vagal and spinal afferent pathways are implicated by basic research. The sensitivity of afferent fibres within these pathways may become altered after acid-induced inflammation and damage, but the severity of symptoms in humans does not necessarily correlate with the degree of inflammation. Gastro-oesophageal reflux disease (GORD) is caused by transient relaxations of the lower oesophageal sphincter, which are triggered by activation of gastric vagal mechanoreceptors. Vagal afferents are therefore an emerging therapeutic target for GORD. Pain in the absence of excess acid reflux remains a major challenge for treatment.

LanguageEnglish
Title of host publicationHandbook of Experimental Pharmacology
EditorsBrendan Canning, Domenico Spina
Pages227-257
Number of pages31
DOIs
Publication statusPublished - 12 Oct 2009
Externally publishedYes

Publication series

NameHandbook of Experimental Pharmacology
Volume194
ISSN (Print)0171-2004

Keywords

  • Gastro-oesophageal reflux
  • Lower oesophageal sphincter
  • Vagal afferents
  • Visceral pain

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Page, A. J., & Blackshaw, L. A. (2009). Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease. In B. Canning, & D. Spina (Eds.), Handbook of Experimental Pharmacology (pp. 227-257). (Handbook of Experimental Pharmacology; Vol. 194). https://doi.org/10.1007/978-3-540-79090-7_7
Page, Amanda J. ; Blackshaw, L. Ashley. / Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease. Handbook of Experimental Pharmacology. editor / Brendan Canning ; Domenico Spina. 2009. pp. 227-257 (Handbook of Experimental Pharmacology).
@inbook{cee9d4bb997846308f4090c358c41c09,
title = "Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease",
abstract = "Oesophageal pain is one of the most common reasons for physician consultation and/or seeking medication. It is most often caused by acid reflux from the stomach, but can also result from contractions of the oesophageal muscle. Different forms of pain are evoked by oesophageal acid, including heartburn and non-cardiac chest pain, but the basic mechanisms and pathways by which these are generated remain to be elucidated. Both vagal and spinal afferent pathways are implicated by basic research. The sensitivity of afferent fibres within these pathways may become altered after acid-induced inflammation and damage, but the severity of symptoms in humans does not necessarily correlate with the degree of inflammation. Gastro-oesophageal reflux disease (GORD) is caused by transient relaxations of the lower oesophageal sphincter, which are triggered by activation of gastric vagal mechanoreceptors. Vagal afferents are therefore an emerging therapeutic target for GORD. Pain in the absence of excess acid reflux remains a major challenge for treatment.",
keywords = "Gastro-oesophageal reflux, Lower oesophageal sphincter, Vagal afferents, Visceral pain",
author = "Page, {Amanda J.} and Blackshaw, {L. Ashley}",
year = "2009",
month = "10",
day = "12",
doi = "10.1007/978-3-540-79090-7_7",
language = "English",
isbn = "9783540790891",
series = "Handbook of Experimental Pharmacology",
pages = "227--257",
editor = "Brendan Canning and Domenico Spina",
booktitle = "Handbook of Experimental Pharmacology",

}

Page, AJ & Blackshaw, LA 2009, Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease. in B Canning & D Spina (eds), Handbook of Experimental Pharmacology. Handbook of Experimental Pharmacology, vol. 194, pp. 227-257. https://doi.org/10.1007/978-3-540-79090-7_7

Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease. / Page, Amanda J.; Blackshaw, L. Ashley.

Handbook of Experimental Pharmacology. ed. / Brendan Canning; Domenico Spina. 2009. p. 227-257 (Handbook of Experimental Pharmacology; Vol. 194).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease

AU - Page, Amanda J.

AU - Blackshaw, L. Ashley

PY - 2009/10/12

Y1 - 2009/10/12

N2 - Oesophageal pain is one of the most common reasons for physician consultation and/or seeking medication. It is most often caused by acid reflux from the stomach, but can also result from contractions of the oesophageal muscle. Different forms of pain are evoked by oesophageal acid, including heartburn and non-cardiac chest pain, but the basic mechanisms and pathways by which these are generated remain to be elucidated. Both vagal and spinal afferent pathways are implicated by basic research. The sensitivity of afferent fibres within these pathways may become altered after acid-induced inflammation and damage, but the severity of symptoms in humans does not necessarily correlate with the degree of inflammation. Gastro-oesophageal reflux disease (GORD) is caused by transient relaxations of the lower oesophageal sphincter, which are triggered by activation of gastric vagal mechanoreceptors. Vagal afferents are therefore an emerging therapeutic target for GORD. Pain in the absence of excess acid reflux remains a major challenge for treatment.

AB - Oesophageal pain is one of the most common reasons for physician consultation and/or seeking medication. It is most often caused by acid reflux from the stomach, but can also result from contractions of the oesophageal muscle. Different forms of pain are evoked by oesophageal acid, including heartburn and non-cardiac chest pain, but the basic mechanisms and pathways by which these are generated remain to be elucidated. Both vagal and spinal afferent pathways are implicated by basic research. The sensitivity of afferent fibres within these pathways may become altered after acid-induced inflammation and damage, but the severity of symptoms in humans does not necessarily correlate with the degree of inflammation. Gastro-oesophageal reflux disease (GORD) is caused by transient relaxations of the lower oesophageal sphincter, which are triggered by activation of gastric vagal mechanoreceptors. Vagal afferents are therefore an emerging therapeutic target for GORD. Pain in the absence of excess acid reflux remains a major challenge for treatment.

KW - Gastro-oesophageal reflux

KW - Lower oesophageal sphincter

KW - Vagal afferents

KW - Visceral pain

UR - http://www.scopus.com/inward/record.url?scp=70349907772&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-79090-7_7

DO - 10.1007/978-3-540-79090-7_7

M3 - Chapter

SN - 9783540790891

T3 - Handbook of Experimental Pharmacology

SP - 227

EP - 257

BT - Handbook of Experimental Pharmacology

A2 - Canning, Brendan

A2 - Spina, Domenico

ER -

Page AJ, Blackshaw LA. Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease. In Canning B, Spina D, editors, Handbook of Experimental Pharmacology. 2009. p. 227-257. (Handbook of Experimental Pharmacology). https://doi.org/10.1007/978-3-540-79090-7_7